View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
December 21, 2017

A look at Bayer’s top performing drugs

Bayer’s bigger earner is clearly Xarelto with sales reaching US$3250m.

By GlobalData Healthcare

Figure 1: Top 10 Selling Products of Bayer AG (US$ mill)

Source: GlobalData, Pharma Intelligence Center, [Accessed 19th Dec 2017]

Figure 1 displays the sales values of the top ten products of Bayer for 2016. Bayer’s bigger earner is clearly Xarelto with sales reaching US$3250m. Strong growth is also expected from Eylea and Mirena, which mean Bayer’s revenues will remain strong in the coming years.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology